Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials. Ottaiano A, Santorsola M, Caraco F, Caraglia M, et al. Lancet Oncol 2022;23:452-454.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ottaiano A, Santorsola M, Caraco F, Caraglia M, et al. Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials. Lancet Oncol 2022;23:452-454.
PMID: 35358452